Vimarsana
Biggest News Aggregation in the World

Transplant Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Transplant Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Transplant Evaluation Today - Breaking & Trending Today

Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait - Vimarsana News

Regrowth Predicts Metastasis in Rectal Cancer Watch and Wait

A large retrospective study addressed the risk of opting for "watch and wait" in rectal cancer.

'Breakthrough': Adjuvant Pembro Ups Survival in Renal Cancer - Vimarsana News

'Breakthrough': Adjuvant Pembro Ups Survival in Renal Cancer

KEYNOTE-564 is the first trial to demonstrate an overall survival benefit with adjuvant immunotherapy in patients with clear cell renal cell carcinoma.

Mixed, 'Intriguing' Result for Stroke Neuroprotective Agent - Vimarsana News

Mixed, 'Intriguing' Result for Stroke Neuroprotective Agent

Two new studies of the potential neuroprotective agent nerinetide for patients with acute ischemic stroke have shown conflicting results, with suggestions of benefit when given very early in the prehospital setting.

No Benefit of EC/IC Bypass vs Meds in Large-Artery Stroke - Vimarsana News

No Benefit of EC/IC Bypass vs Meds in Large-Artery Stroke

Despite surgical advances, adding extracranial-intracranial bypass to medical therapy does not reduce stroke or death in symptomatic occlusion of the internal carotid or middle cerebral artery.

Liver Transplant in CRC: Who Might Benefit? - Vimarsana News

Liver Transplant in CRC: Who Might Benefit?

Liver transplant might cure liver metastases in a small subset of patients with CRC but identifying which patients could benefit most remains a challenge.